Claudia E Mason, MD | |
525 Okeechobee, Cleveland Clinic Florida Health And Wellness Center, West Palm Beach, FL 33401 | |
(561) 804-0200 | |
(561) 804-0222 |
Full Name | Claudia E Mason |
---|---|
Gender | Female |
Speciality | Obstetrics/gynecology |
Experience | 45 Years |
Location | 525 Okeechobee, West Palm Beach, Florida |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1114011590 | NPI | - | NPPES |
000431000 | Medicaid | FL |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207V00000X | Obstetrics & Gynecology | ME102466 (Florida) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Cleveland Clinic Hospital | Weston, FL | Hospital |
Jupiter Medical Center | Jupiter, FL | Hospital |
Good Samaritan Medical Center | West palm beach, FL | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Cleveland Clinic Florida A Nonprofit Corporation | 7911807128 | 618 |
News Archive
American Medical Alert Corp. (NASDAQ: AMAC) a provider of healthcare communication services and advanced telehealth monitoring technologies, today announced operating results for the quarter and six months ended June 30, 2009.
Researchers at the University of Pennsylvania School of Medicine identified a combination therapy as a way to sensitize resistant human cancer cells to a treatment currently being tested in clinical trials They propose that the therapy may help to selectively eliminate cancer cells while leaving healthy cells intact, providing a cancer treatment with fewer side effects.
How you perceive and react to stressful events is more important to your health than how frequently you encounter stress, according to health researchers from Penn State and Columbia University.
Since Rofecoxib (Vioxx) was withdrawn from the worldwide market based on the safety findings of the Adenomatous Polyp Prevention on Vioxx (APPROVe) study, the uncertainty around the cardiovascular safety of NSAIDs and COX-2 inhibitors remains and leaves practitioners with difficult management decisions for the hundreds of millions of patients worldwide who continue to require pain-relieving therapy to maintain an acceptable quality of life.
For the first time, researchers have used a healthy person's complete genome sequence to predict his risk for dozens of diseases and how he will respond to several common medications. The risk analysis, from the Stanford University School of Medicine, also incorporates more-traditional information such as a patient's age and gender and other clinical measurements.
› Verified 6 days ago
Entity Name | Cleveland Clinic Florida A Nonprofit Corporation |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1215989298 PECOS PAC ID: 7911807128 Enrollment ID: O20040113000394 |
News Archive
American Medical Alert Corp. (NASDAQ: AMAC) a provider of healthcare communication services and advanced telehealth monitoring technologies, today announced operating results for the quarter and six months ended June 30, 2009.
Researchers at the University of Pennsylvania School of Medicine identified a combination therapy as a way to sensitize resistant human cancer cells to a treatment currently being tested in clinical trials They propose that the therapy may help to selectively eliminate cancer cells while leaving healthy cells intact, providing a cancer treatment with fewer side effects.
How you perceive and react to stressful events is more important to your health than how frequently you encounter stress, according to health researchers from Penn State and Columbia University.
Since Rofecoxib (Vioxx) was withdrawn from the worldwide market based on the safety findings of the Adenomatous Polyp Prevention on Vioxx (APPROVe) study, the uncertainty around the cardiovascular safety of NSAIDs and COX-2 inhibitors remains and leaves practitioners with difficult management decisions for the hundreds of millions of patients worldwide who continue to require pain-relieving therapy to maintain an acceptable quality of life.
For the first time, researchers have used a healthy person's complete genome sequence to predict his risk for dozens of diseases and how he will respond to several common medications. The risk analysis, from the Stanford University School of Medicine, also incorporates more-traditional information such as a patient's age and gender and other clinical measurements.
› Verified 6 days ago
Mailing Address | Practice Location Address |
---|---|
Claudia E Mason, MD 2950 Cleveland Clinic Blvd, Weston, FL 33331-3609 Ph: (954) 659-5000 | Claudia E Mason, MD 525 Okeechobee, Cleveland Clinic Florida Health And Wellness Center, West Palm Beach, FL 33401 Ph: (561) 804-0200 |
News Archive
American Medical Alert Corp. (NASDAQ: AMAC) a provider of healthcare communication services and advanced telehealth monitoring technologies, today announced operating results for the quarter and six months ended June 30, 2009.
Researchers at the University of Pennsylvania School of Medicine identified a combination therapy as a way to sensitize resistant human cancer cells to a treatment currently being tested in clinical trials They propose that the therapy may help to selectively eliminate cancer cells while leaving healthy cells intact, providing a cancer treatment with fewer side effects.
How you perceive and react to stressful events is more important to your health than how frequently you encounter stress, according to health researchers from Penn State and Columbia University.
Since Rofecoxib (Vioxx) was withdrawn from the worldwide market based on the safety findings of the Adenomatous Polyp Prevention on Vioxx (APPROVe) study, the uncertainty around the cardiovascular safety of NSAIDs and COX-2 inhibitors remains and leaves practitioners with difficult management decisions for the hundreds of millions of patients worldwide who continue to require pain-relieving therapy to maintain an acceptable quality of life.
For the first time, researchers have used a healthy person's complete genome sequence to predict his risk for dozens of diseases and how he will respond to several common medications. The risk analysis, from the Stanford University School of Medicine, also incorporates more-traditional information such as a patient's age and gender and other clinical measurements.
› Verified 6 days ago
Tanya Puklus Hoke, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 770 Northpoint Pkwy Ste 100, West Palm Beach, FL 33407 Phone: 561-655-3331 | |
Ernest E Jabour, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 1411 N Flagler Dr, Suite 3800, West Palm Beach, FL 33401 Phone: 561-835-1900 Fax: 561-835-1960 | |
Howard M Goodman, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1309 N Flagler Dr, Florida Cancer Specialists P L, West Palm Beach, FL 33401 Phone: 561-366-4100 Fax: 561-366-4189 | |
Peter A Sherman, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 770 Northpoint Pkwy Ste 200, West Palm Beach, FL 33407 Phone: 561-655-3331 Fax: 561-655-3744 | |
Dr. Marx Jean Louis Santel, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 418 34th St, West Palm Beach, FL 33407 Phone: 561-228-8733 Fax: 561-337-6965 | |
Dr. Engelbert Patrick Bonilla, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 770 Northpoint Pkwy Ste 200, West Palm Beach, FL 33407 Phone: 561-626-3800 Fax: 561-624-6364 |